News

30/04/2021

Robotic device that induces hallucinations allows scientists to identify the brain network responsible for hallucinations in Parkinson’s disease

A team of researchers at the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, together with scientists at École Polythecnique Fédérale de Lausanne (EPFL), describe t...

30/04/2021

Sant Pau participates in CARDIOPATCH, an European project that boosts cooperation between the biomedical industry and the 3D printing sector

The partners of the European project CARDIOPATCH will present the website of the initiative the 30th of April in a virtual event. The interactive platform is a dynamic environment that aims to promote...

22/04/2021

The response of blood flow to posture changes in stroke patients signals errors in brain autoregulation

An international team with participation of the Cerebrovascular Diseases group at IIB Sant Pau and led by ICFO researchers, has carried out a pooled analysis, combining the results of three studies ab...

20/04/2021

Exheus receives the ACCIÓ’s ‘Startup Capital’ grant to continue improving people’s Health

Exheus, a spin-off of the Sant Pau Research Institute – IIB Sant Pau and CREB UPC that analyzes gene expression using artificial intelligence, has received a grant worth 75,000 euros within the f...

31/03/2021

Sant Pau develops and administers the first CAR-T of its own production for Hodgkin and non-Hodgkin lymphoma T in Europe

The first CAR-T immunotherapy drug produced entirely in Sant Pau and administered to the first patient, is part of a clinical trial of the centre itself, pioneer in Europe, of phase I CAR-T immunother...